Breaking News

Pharmalogic Acquires Majority Stake in Agilera Pharma

Enhances its capabilities across development, manufacturing, and global distribution of commercial and clinical therapeutic radiopharmaceuticals.

PharmaLogic Holdings Corp., a contract development and manufacturing organization (CDMO) specialized in radiopharmaceuticals, has completed its previously announced acquisition of a majority stake in Agilera Pharma AS from the Institute for Energy Technology (IFE) in Norway.

“The addition of Agilera’s capabilities to PharmaLogic marks a key milestone in our expansion strategy into radiopharmaceutical therapeutics,” said Etienne Montagut, President and CEO of PharmaLogic. “Their proven expertise in the development and manufacturing of commercial radiopharmaceutical therapies, evidenced by successful distribution to over 30 countries, significantly enhances our end-to-end solutions. We warmly welcome the talented Agilera team and look forward to shaping the future of radiopharmaceuticals together.”

More Pharma Industry Acquisitions

Don’t miss Contract Pharma’s Pharmaceutical Industry Mergers & Acquisitions Roundup.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters